What is Orbem?
Orbem is a deep-tech enterprise that specializes in the development of AI-powered imaging solutions. By integrating accelerated magnetic resonance imaging (MRI) with sophisticated artificial intelligence, the company enables the non-invasive classification and analysis of biological and material samples. This technology effectively reveals internal data that is typically hidden beneath the surface, offering a transformative approach to quality inspection and diagnostic accuracy. Originating as a spin-off from the Technical University of Munich, the company leverages its academic roots to drive industrial efficiency and sustainability. Its core value proposition lies in making MRI technology faster, more accessible, and highly scalable, thereby reshaping how global industries utilize hidden biological information to optimize their operational workflows.
How much funding has Orbem raised?
Orbem has raised a total of $96.6M across 2 funding rounds:
Series A
$31.6M
Series B
$65M
Series A (2023): $31.6M with participation from The Venture Collective, 83North, La Famiglia, and Possible Ventures
Series B (2026): $65M led by Supernova Invest, 83North, Innovation Industries, General Catalyst, Possible Ventures, and The Venture Collective
Key Investors in Orbem
General Catalyst
General Catalyst is a prominent venture capital firm that partners with founders to build enduring enterprises by providing strategic capital and operational expertise across diverse sectors including technology and healthcare.
83North
83North is a global venture capital firm managing over $2.2 billion, focused on investing in exceptional entrepreneurs to build category-leading companies through collaborative growth strategies.
Supernova Invest
Supernova Invest is a specialized deeptech investor that provides patient capital and industry expertise to high-growth startups in the healthcare, industrial, and cleantech sectors.
What's next for Orbem?
With the successful closure of this major strategic investment, Orbem is poised to enter a phase of rapid commercial expansion and technological refinement. The company is expected to focus on deepening its market penetration within the healthcare and agricultural sectors, where its AI-driven imaging provides a distinct competitive advantage. Future strategic initiatives will likely involve the scaling of its global team and the further integration of its imaging platforms into existing industrial supply chains. As the company transitions from a high-growth startup to an established industry player, the focus will remain on maintaining its technological edge while addressing the increasing demand for sustainable and efficient data-driven solutions in complex biological environments.
See full Orbem company page
